Last $0.98 USD
Change Today -0.04 / -3.92%
Volume 29.5K
VSCI On Other Exchanges
As of 8:10 PM 08/19/14 All times are local (Market data is delayed by at least 15 minutes).

vision-sciences inc (VSCI) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/7/14 - $1.75
52 Week Low
11/1/13 - $0.78
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for VISION-SCIENCES INC (VSCI)

Related News

No related news articles were found.

vision-sciences inc (VSCI) Related Businessweek News

No Related Businessweek News Found

vision-sciences inc (VSCI) Details

Vision-Sciences, Inc., through its subsidiaries, designs, develops, manufactures, and markets endoscopy products. It operates through Medical and Industrial segments. The Medical segment designs, manufactures, and sells endoscopy-based products, including flexible fiber and video endoscopes; and EndoSheath disposables. This segment offers cystoscopes to urologists; bronchoscope to intensivists, pulmonologists, thoracic surgeons, and other airway-related physicians; trans-nasal esophagoscopy to general surgeons, primarily bariatric and gastroesophageal reflux disease surgeons, and gastroenterology physicians, as well as ear, nose, and throat (ENT) physicians and others; and ENT endoscopes to ENT physicians and speech pathologists. The Industrial segment designs, manufactures, and sells borescopes products, such as modulars, slim levers, knobs, battery operated portable flexible borescopes, industrial videoscopes, and portable video processors primarily to the aircraft engine manufacturing and aircraft engine maintenance industries. The company distributes its products through direct sales representatives in the United States; and through independent distributors in Europe, Asia, Australia, Canada, the Middle East, Africa, and central and South America. The company was founded in 1987 and is headquartered in Orangeburg, New York.

105 Employees
Last Reported Date: 05/30/14
Founded in 1987

vision-sciences inc (VSCI) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $210.9K
Vice President of Disposables Operations
Total Annual Compensation: $170.0K
Vice President of Machida
Total Annual Compensation: $155.0K
Compensation as of Fiscal Year 2014.

vision-sciences inc (VSCI) Key Developments

Vision-Sciences Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended June 30, 2014

Vision-Sciences Inc. reported unaudited consolidated earnings results for the first quarter ended June 30, 2014. For the quarter, the company reported net sales of USD 3,752,000 against USD 3,652,000 a year ago. Operating loss was USD 1,878,000 against USD 2,389,000 a year ago. Loss before provision for income taxes was USD 1,977,000 against USD 2,434,000 a year ago. Net loss was USD 1,977,000 against USD 2,434,000 a year ago. Net loss per common share - basic and diluted was USD 0.04 against USD 0.05 a year ago. Net cash used in operating activities was USD 945,000 against USD 1,419,000 a year ago. Purchases of property and equipment were USD 25,000. Net sales were increased by 3% compared the same period a year ago, attributable to higher sales in the critical care/pulmonology market of its endoscopes and EndoSheath technology.

Vision-Sciences Inc. Amends Certificate of Incorporation

On July 31, 2014, Vision-Sciences Inc. held its 2014 Annual Meeting of Stockholders. At the annual meeting, the stockholders amended the company's Certificate of Incorporation to increase the number of authorized shares of common stock.

Vision-Sciences Inc. to Report Q1, 2015 Results on Aug 04, 2014

Vision-Sciences Inc. announced that they will report Q1, 2015 results at 5:00 PM, Eastern Standard Time on Aug 04, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VSCI:US $0.98 USD -0.04

VSCI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bacterin International Holdings Inc $4.88 USD 0.00
Cardica Inc $1.16 USD +0.01
Cytori Therapeutics Inc $1.64 USD 0.00
Stereotaxis Inc $2.89 USD -0.05
Uroplasty Inc $2.89 USD +0.01
View Industry Companies

Industry Analysis


Industry Average

Valuation VSCI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.7x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VISION-SCIENCES INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at